SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Merrimack Pharmaceuticals Inc. to Present Preclinical Data at the 24th EORTC-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics